Shares Outstanding for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported diluted shares outstanding is 2.04B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
2.04B
YoY change
+0.7%
5Y CAGR
-2.0%
Peak year (2020)
2.26B
Latest annual
2.04B
Shares Outstanding history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Shares Outstanding history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 2.04B | +0.7% | ||
| 2024 | 2.03B | -2.5% | ||
| 2023 | 2.08B | -3.2% | ||
| 2022 | 2.15B | -4.4% | ||
| 2021 | 2.25B | -0.6% | ||
| 2020 | 2.26B | +31.9% | ||
| 2019 | 1.71B | +4.6% | ||
| 2018 | 1.64B | -0.9% | ||
| 2017 | 1.65B | -1.7% | ||
| 2016 | 1.68B | +0.1% | ||
| 2015 | 1.68B | +0.5% | ||
| 2014 | 1.67B | +0.5% | ||
| 2013 | 1.66B | -1.5% | ||
| 2012 | 1.69B | -1.7% | ||
| 2011 | 1.72B | -0.6% | ||
| 2010 | 1.73B | -12.7% | ||
| 2009 | 1.98B | -1.1% | ||
| 2008 | 2.00B | +1.1% | ||
| 2007 | 1.98B | +0.9% | ||
| 2006 | 1.96B | -1.0% | ||
| 2005 | 1.98B | +0.4% | ||
| 2004 | 1.98B | +1.3% | ||
| 2003 | 1.95B | -3.3% | ||
| 2002 | 2.02B | +2.6% | ||
| 2001 | 1.97B | -1.6% | ||
| 2000 | 2.00B | -1.5% | ||
| 1999 | 2.03B | -0.2% | ||
| 1998 | 2.03B | -0.5% | ||
| 1997 | 2.04B | +0.3% | ||
| 1996 | 2.04B | +0.2% | ||
| 1995 | 2.03B | -0.2% | ||
| 1994 | 2.04B | -1.3% | ||
| 1993 | 2.06B | +0.9% | ||
| 1992 | 2.04B | -1.6% | ||
| 1991 | 2.08B | -0.2% | ||
| 1990 | 2.08B | +0.3% | ||
| 1989 | 2.08B | -0.7% | ||
| 1988 | 2.09B | -2.2% | ||
| 1987 | 2.14B | — |
Shares Outstanding values are taken from Bristol-Myers Squibb's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Bristol-Myers Squibb (BMY) most recent annual diluted shares outstanding stands at 2.04B (2025) – edged up 0.7% year-over-year.
Bristol-Myers Squibb diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is -2.0%, with a net decline across the window.
Bristol-Myers Squibb diluted shares outstanding declined from 2.26B in 2020 to 2.04B in 2025, a 9.6% drawdown.
The highest annual diluted shares outstanding of 2.26B was reported in 2020. The lowest in the available history was 1.64B in 2018.
Bristol-Myers Squibb (BMY) sits 4th of 8 Healthcare peers we track on this metric, against a peer median of 1.34B.
Bristol-Myers Squibb Shares Outstanding by Year
Bristol-Myers Squibb Shares Outstanding 2025: 2.04B
Bristol-Myers Squibb diluted shares outstanding in 2025 was 2.04B, edged up 0.7% from 2024.
Bristol-Myers Squibb Shares Outstanding 2024: 2.03B
Bristol-Myers Squibb diluted shares outstanding in 2024 was 2.03B, edged down 2.5% below 2023.
Bristol-Myers Squibb Shares Outstanding 2023: 2.08B
Bristol-Myers Squibb diluted shares outstanding in 2023 was 2.08B, edged down 3.2% below 2022.
Bristol-Myers Squibb Shares Outstanding 2022: 2.15B
Bristol-Myers Squibb diluted shares outstanding in 2022 was 2.15B, edged down 4.4% below 2021.
Bristol-Myers Squibb Shares Outstanding 2021: 2.25B
Bristol-Myers Squibb diluted shares outstanding in 2021 was 2.25B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Shares Outstanding
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's diluted shares outstanding?
- Latest reported diluted shares outstanding for Bristol-Myers Squibb (BMY) is 2.04B (period ending December 31, 2025).
How has Bristol-Myers Squibb diluted shares outstanding changed year-over-year?
- Bristol-Myers Squibb (BMY) diluted shares outstanding changed +0.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb diluted shares outstanding?
- Bristol-Myers Squibb (BMY) diluted shares outstanding compound annual growth rate is -2.0% over the most recent 5 years available.
When did Bristol-Myers Squibb diluted shares outstanding hit its highest annual value?
- Bristol-Myers Squibb diluted shares outstanding reached its highest annual value of 2.26B in 2020.
What was Bristol-Myers Squibb diluted shares outstanding in 2024?
- Bristol-Myers Squibb (BMY) diluted shares outstanding in 2024 was 2.03B.
What was Bristol-Myers Squibb diluted shares outstanding in 2025?
- Bristol-Myers Squibb (BMY) diluted shares outstanding in 2025 was 2.04B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.